Ticker Scorecard - TEVA Basics Company: Teva Pharmaceutical Industries IPO Date: March 26, 1990 Sector: Healthcare Industry: Pharma Market Cap: $19.18B Activated in VL: True Average Daily Range Avg Daily Range: $0.39 | 1.30% Avg Daily Range (30 D): $0.28 | 1.49% Avg Daily Range (90 D): $0.28 | 1.48% Institutional Daily Volume Avg Daily Volume: 7.73M Avg Daily Volume (30 D): 11.45M Avg Daily Volume (90 D): 8.43M Trade Size Avg Trade Size (Sh.): 246 Avg Trade Size (Sh.) (30 D): 190 Avg Trade Size (Sh.) (90 D): 181 Institutional Trades Total Inst.Trades: 77,998 Avg Inst. Trade: $2.26M Avg Inst. Trade (30 D): $4.23M Avg Inst. Trade (90 D): $4.35M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 14 Market Closing Trades Avg Closing Trade: $5.19M Avg Closing Trade (30 D): $15.24M Avg Closing Trade (90 D): $12.45M Avg Closing Volume: 249.16K     News Feb 22, 2025 @ 7:30 AM Communiqué de presse : ECCO 2025 : de nouvel... Source: N/A Feb 22, 2025 @ 7:30 AM Press Release: ECCO 2025: new duvakitug data reinf... Source: N/A Feb 22, 2025 @ 7:20 AM Teva and Sanofi Present New Positive Phase 2b Stud... Source: N/A Feb 21, 2025 @ 3:00 PM Hyperlipidemia Drugs Market Size to Promote USD 31... Source: Towards Healthcare Feb 21, 2025 @ 11:00 AM Teva and Alvotech Announce SELARSDIâ„¢ (usteki... Source: N/A Financials   TTM Q4 2024 FY 2024 Basic EPS $-1.45 $-.19 $-1.45 Diluted EPS $-1.45 $-.19 $-1.45 Revenue $ 16.54B $ 4.23B $ 16.54B Gross Profit $ 8.06B $ 2.12B $ 8.06B Net Income / Loss $ -1959M $ -275M $ -1959M Operating Income / Loss $ -303M $ -29M $ -303M Cost of Revenue $ 8.48B $ 2.11B $ 8.48B Net Cash Flow $ 74M $ -18M $ 74M PE Ratio     Splits Jul 01, 2004:   1:2 Dec 06, 2002:   1:2 Feb 23, 2000:   1:2